Experts assess the potential of colchicine 0.5 mg to treat residual risk for atherosclerotic cardiovascular disease (ASCVD) in patients with immune-mediated inflammatory diseases (IMIDs).
North Bethesda, Maryland (PRWEB) April 26, 2022 The International Society for Pharmaceutical Engineering (ISPE) today announced the 2022 Facility of the
Healio Psoriatic Disease | We are now more than 2 years into the COVID-19 pandemic with more than 80 million people infected and nearly 1 million deaths in the United States alone. Throughout this pandemic, Healio Psoriatic Disease has aimed to provide you with the most current and rigorous scientific findings while recognizing uncertainty when it exists and encouraging shared decision making with patients when necessary.